Article
Version 1
Preserved in Portico This version is not peer-reviewed
Combination Therapy for Multi-Drug-Resistant Mycoplasma genitalium
Version 1
: Received: 20 September 2024 / Approved: 21 September 2024 / Online: 24 September 2024 (03:49:18 CEST)
How to cite: Kenyon, C. Combination Therapy for Multi-Drug-Resistant Mycoplasma genitalium. Preprints 2024, 2024091671. https://doi.org/10.20944/preprints202409.1671.v1 Kenyon, C. Combination Therapy for Multi-Drug-Resistant Mycoplasma genitalium. Preprints 2024, 2024091671. https://doi.org/10.20944/preprints202409.1671.v1
Abstract
In Belgium, around a quarter of M. genitalium infections are resistant to both macrolides and fluoroquinolones -termed multi-drug-resistant (MDR) infections. It is unclear what the best treatment is for these infections. We report the first two cases of MDR M. genitalium urethritis treated with combination therapy of minocycline, metronidazole, methenamine and pristinamycin. In both cases, this treatment resulted in microbiological and clinical cure.
Keywords
M. genitalium; minocycline; metronidazole; methenamine; pristinamycin; AMR
Subject
Medicine and Pharmacology, Internal Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment